SEC Filing Details
Document Details
Form
Filing Date
January 09, 2026
Document Date
January 07, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Garland J. Scott